BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at …

– Deep Learning Algorithms have the potential to unlock mechanisms of tissue regeneration for applications in age-related disease – ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today announced that Co-CEO Dr. Michael D. West, will give a lecture at the Mensa Annual Gathering today titled, “Hayflick Rewound: Implications of Reversing the Aging of Human Cells.” Dr. West will discuss the impact of aging on society, as well as fundamental advances in understanding its causes and strategies to intervene using regenerative medicine. Dr. West will describe an online Artificial Intelligence (AI) and Deep Learning (DL) resource called “Embryonic.AI” being launched this week by LifeMap Sciences, Inc., a BioTime subsidiary, for beta testing and designed to discover novel treatments…


Link to Full Article: BioTime Presents Online Resource for Applying Artificial Intelligence to Stem Cell Biology at …